Company: PGEN
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001356090-25-000024
Chunk: 25

Company: PRECIGEN, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 1
Chunk 25
---
 and diluted net loss per share were the same for all periods presented.In accordance with ASC 260, the control number for determining whether including potential common shares in the diluted earnings per share, or EPS, computation would be antidilutive should be income from continuing operations. As a result, if there is a loss from continuing operations, diluted EPS would be computed in the same manner as basic EPS is computed, even if the entity has net income after adjusting for a discontinued operation.The following potentially dilutive securities as of June 30, 2025 and 2024 have been excluded from the above computations of diluted weighted average shares outstanding for the three and six months then ended as they would have been anti-dilutive:

14

June 30,20252024Options29,078,506 27,403,769 Restricted stock units2,472,686 786,709 Performance stock units2,594,000 — Total34,145,192 28,190,478 The table above does not include 54,937,413 shares of common stock into which the Series A Preferred Stock is currently convertible and 52,666,669 shares of common stock for which the Warrants are currently exercisable, in each case as of June 30, 2025, and excludes additional shares of common stock that could become issuable as a result of (i) the associated PIK dividends for these instruments (as defined below) and (ii) potential increases to the conversion rate of the Series A Preferred Stock pursuant to the terms thereof. WarrantsThe Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For equity-classified warrants, the